Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Prognostic, Predictive, and POC: Biomarkers from Research to Clinic

Prognostic, Predictive, and POC: Biomarkers from Research to Clinic

Date: Thursday, 15 January 2015 - Friday, 16 January 2015
Location: San Diego, California, USA

Keynote Speakers

Howard Federoff

Howard Federoff
Professor, Georgetown University Medical Center

Mark Curran

Mark Curran
Vice President, Janssen Pharmaceutical Research And Development/Johnson & Johnson

Felix Frueh

Felix Frueh
CSO, Human Longevity Inc

Baolin Zhang

Baolin Zhang
Senior Investigator, CDER Food And Drug Administration

Jan Groen

Jan Groen
CEO, MDxHealth SA

Razelle Kurzrock

Razelle Kurzrock
Director, University of California San Diego

Shawn Baker

Shawn Baker
Chief Science Officer/Chief Executive Officer, AllSeq Inc


This conference brings together researchers from academic institutions and industry to discuss the utilization/deployment of biomarkers in research settings, the clinic, and point-of-care (POC) setting.

The focus of the conference begins with oncology (cancer) biomarkers but continues beyond into other disease areas such as cardiovascular disease biomarkers, CNS biomarkers, diabetes biomarkers, renal biomarkers, hepatic disease biomarkers.

Various classes of biomarkers are presented in this conference:  Classical cancer biomarkers, molecular signatures for cancer based on gene expression profiles, microRNA-based biomarkers, protein expression-based biomarkers, and epigenetic biomarkers.

One of the revolutions currently taking place is the movement of diagnostics towards the point-of-care and more recently with a smartphone or other telemetry-based approach towards the mobile point-of-care (mPOC).  This conference focuses on this emerging trend.

The ultimate goal of this conference is to bring together the stakeholders studying and utilizing biomarkers in many disease areas for up-to-date information exchange as well as extensive networking opportunities.

Present Your Research in a Poster at this Conference. Poster Submission Deadline:  January 9, 2015

Agenda Topics

  • Cardiovascular and Metabolic Diseases
  • Developing Diagnostics and Therapeutics in CNS Diseases using Biomarkers
  • Examination of Prognostic versus Predictive Biomarkers
    • Algorithms for Prediction and Response
    • Commercial Impact and Clinical Adoption
    • Current Examples in the Clinic and their Impact
    • Disease Classes Addressed Currently
  • Immunology Biomarkers and the Microbiome
  • Oncology Biomarkers: Research to Clinical Trajectory
    • Various Cancer Classes such as Breast Cancer, Colorectal Cancer, Lung Cancer, GI Cancers
  • Point-of-Care Diagnostics and Mobile Point-of-Care (mPOC) Diagnostics
    • Biomarkers
    • Technologies for Deployment
  • R&D Pipeline of Markers with Associated Therapeutics
  • The Impact of Next-Generation Sequencing (NGS) on Biomarker Analysis
    • Clinical Applications of RNA-Seq
  • Various Classes of Biomarkers: Protein, Gene-Expression, microRNA, Epigenetic

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Confirmed Speakers to date

Rajesh Ambasudhan, Research Assistant Professor, Sanford-Burnham Medical Research Institute
Christos Argyropoulos, Assistant Professor, Division of Nephrology, University of New Mexico
David Cheresh, Distinguished Professor of Pathology , University of California-San Diego
Donald Durden, Pediatric Researcher, University Of California School Of Medicine
Denise Faustman, Director, Immunobiology Laboratory & Associate Professor of Medicine, Massachusetts General Hospital/Harvard Medical School
Anand Giddabasappa, Principal Scientist, Global Science and Technology, Pfizer
Sridhar Iyengar, Founder/Director, Misfit Wearables
Filip Janku, Associate Professor, Center Medical Director, Clinical and Translational Research Center, The University of Texas MD Anderson Cancer Center
Greg Jones, Director of Business Development and Technical Affairs, MDxHealth SA
David Kallend, Vice President, Global Medical Director, The Medicines Company
Serguei Kozlov, Leidos Biomedical Research, Inc. Principal Scientist, Center for Advancer Preclinical Research, NIH
Luke Lee, Director, Global Health Research and Technology (BIGHEART), NUS
Scott Lippman, Associate Vice Chancellor, University of California-San Diego
Terri McClanahan, Director, Profiling & Expression, Merck Biologics Discovery
William Mobley, Distinguished Professor and Chair, Department of Neurosciences, University of California-San Diego
Chamindie Punyadeera, Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology
George Zouridakis, Professor, University of Houston

Exhibition Sponsors Media Sponsors Networking

Add to Calendar ▼2015-01-15 00:00:002015-01-16 00:00:00Europe/LondonPrognostic, Predictive, and POC: Biomarkers from Research to ClinicPrognostic, Predictive, and POC: Biomarkers from Research to Clinic in San Diego, California, USASan Diego, California,